Clin2
NCT07079761Worth exploringRecruiting

PTSD treatment study with a hormone-like drug

Post Traumatic Stress Disorder

Part of Injuries & trauma, Mental health clinical trials.

This trial tests if a single infusion of allopregnanolone (a natural brain chemical) can help people with PTSD reduce fear responses and improve memory processing. It may offer a new way to treat PTSD by targeting how the brain stores traumatic memories.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
96 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You have had PTSD symptoms for more than 3 months.
  • You are generally healthy and not taking certain medications that could interfere with the study drug.
  • You agree to avoid alcohol for 2 weeks and nicotine, marijuana, or other drugs for 4 weeks before the study sessions.
  • If you are a woman with a natural menstrual cycle, you and your partner must use two types of effective birth control (not hormonal pills, but an IUD or Nuvaring is okay) starting a week before the infusion and for a month after.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05788302Recruiting
Studying prolonged exposure for PTSD and how it helps

This trial studies how a therapy called “prolonged exposure” works for people with post-traumatic stress disorder (PTSD). You may be able to join if you have PTSD, are interested in starting prolonged exposure, and meet other safety and participation rules.

Boston, Massachusetts
NCT05943665Recruiting· Phase 2
MDMA-assisted therapy for PTSD and alcohol use in veterans

This study tests whether MDMA, given in a controlled clinical setting, can reduce symptoms of PTSD and alcohol use disorder in veterans. It also combines the medication with structured therapy sessions to help you manage symptoms without relying on alcohol or other substances.

Providence, Rhode Island
NCT07664631Not yet recruiting· Phase 1
Testing stimulant medications for PTSD

This study tests whether stimulant medications can help treat PTSD symptoms. Researchers want to see if these medications are safe and effective for people with PTSD.

Chicago, Illinois
NCT07704762Not yet recruiting· Phase 2
MDMA-assisted therapy for PTSD in military members

This trial tests if MDMA (a drug that can help with therapy) along with talk therapy can help military members with PTSD. It is designed for active duty, National Guard, or Reserve service members who have had PTSD for at least six months.

NCT07456696Recruiting· Phase 3
TSND-201 for PTSD treatment study

This trial tests if an investigational drug called TSND-201 can help treat PTSD. It is for people who have tried at least one other PTSD treatment before.

Tucson, Arizona
NCT06577636Recruiting· Phase 2
Dream induction with anesthesia for PTSD

This trial tests whether inducing dreams during light anesthesia can help treat post-traumatic stress disorder (PTSD). You'll have a low-risk procedure where doctors monitor your brain activity and guide dreams to reduce PTSD symptoms.

Stanford, California

Hear when a new PTSD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.